U.S. lawmakers are being urged by Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) to explore the provisions contained in a bill...
The Utah Legislature has approved a bill to safeguard government employees from discrimination for using medical cannabis with a legitimate doctor's prescription.
After being given the go-ahead by members...
Adult-use cannabis markets are yet to transpire across New York and its competitor New Jersey, despite the fact that the bordering U.S. states both recently legalized the plant for recreational sale and...
Amid the realization that hopes are fading for federal cannabis legalization, market traders have acknowledged a loss in the value of U.S. cannabis stocks.
Attracting awareness to the issue was AdvisorShares...
As cannabis legalization continues to sweep across the United States, the subject of payment is being discussed more frequently.
There's no denying the fact that legal roadblocks are preventing cannabis...
Canadian cannabis producer Tilray Inc. has closed two previously-confirmed deals to purchase Alpine Beer Co. and Green Flash Brewing.
On December 17, the Canadian cannabis producer completed an acquisition...
The most recently discovered strain of coronavirus, the Omicron variant, is currently spreading across the globe. So intense is the outbreak that cannabis companies are struggling with supply constraints.
A...
The cheering that filled the air during a December rally at downtown Austin’s Republic Square Park grew significantly louder when El Paso Democrat Beto O’Rourke announced what many of his supporters...
Pfizer, a New York-based Big Pharma company with a global portfolio that features vaccines and well-known pharmaceutical drugs – such as Viagra and Xanax – is preparing to make a bold entry into the...
The future may not have room for cashless ATMs in cannabis stores. Based on a warning from credit card giant Visa, cashless ATM machines have been adopted in a careless way by cannabis retail dispensary...
A White House proposal to ease the process of researching Schedule I drugs, such as cannabis and psychedelics, has gained a seal of approval from the Drug Enforcement Administration (DEA) and National...
The head of the nation’s leading federal drug research agency, the National Institute on Drug Abuse (NIDA), claims that she has not yet observed any proof that occasional adult cannabis consumption is...
